AdaptHealth Corp. (AHCO)
| Market Cap | 1.56B +49.8% |
| Revenue (ttm) | 3.29B +1.2% |
| Net Income | -79.63M |
| EPS | -0.59 |
| Shares Out | 133.12M |
| PE Ratio | n/a |
| Forward PE | 11.89 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,953,016 |
| Open | 11.48 |
| Previous Close | 11.42 |
| Day's Range | 11.37 - 11.92 |
| 52-Week Range | 7.95 - 13.43 |
| Beta | 1.57 |
| Analysts | Strong Buy |
| Price Target | 13.80 (+17.65%) |
| Earnings Date | May 5, 2026 |
About AHCO
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for AHCO stock is "Strong Buy." The 12-month stock price target is $13.8, which is an increase of 17.65% from the latest price.
News
AdaptHealth price target raised to $18 from $17 at Baird
Baird analyst Eric Coldwell raised the firm’s price target on AdaptHealth (AHCO) to $18 from $17 and keeps an Outperform rating on the shares. The firm updated its model following
AdaptHealth price target raised to $16 from $14 at Canaccord
Canaccord raised the firm’s price target on AdaptHealth (AHCO) to $16 from $14 and keeps a Buy rating on the shares. The firm updated its model following Q1 results where
AdaptHealth price target lowered to $14 from $15 at UBS
UBS lowered the firm’s price target on AdaptHealth (AHCO) to $14 from $15 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source for
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Earnings Call Transcript: Q1 2026
Revenue and organic growth exceeded guidance, driven by a major capitated contract and strong segment performance. Labor and startup costs impacted Q1 margins, but normalization and full contract ramp are expected to boost profitability and cash flow in the coming quarters.
AdaptHealth reports Q1 EPS (12c), consensus 1c
Reports Q1 revenue $819.799M, consensus $796.63M. “The opening months of 2026 have set the stage for what will be a defining year for AdaptHealth (AHCO),” said Suzanne Foster, Chief Executive
AdaptHealth sees FY26 net revenue $3.45B-$3.52B, consensus $3.47B
For fiscal year 2026, the Company is raising net revenue guidance by $10 million and maintaining Adjusted EBITDA and free cash flow guidance, as follows: Net revenue of $3.45 billion
AdaptHealth Corp. Announces First Quarter 2026 Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth price target raised to $11 from $9.50 at Jefferies
Jefferies analyst Brian Tanquilut raised the firm’s price target on AdaptHealth (AHCO) to $11 from $9.50 and keeps a Hold rating on the shares. The relative underperformance of healthcare services
AdaptHealth Corp. Announces First Quarter 2026 Earnings Release Date and Conference Call
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth price target raised to $14 from $13 at Truist
Truist raised the firm’s price target on AdaptHealth (AHCO) to $14 from $13 and keeps a Buy rating on the shares as part of a broader research note previewing Q1
AdaptHealth announces refinancing of senior secured credit facility
AdaptHealth (AHCO) announced that it has closed a $1.1B senior secured credit facility, consisting of a $325M Term Loan A, a $325M Delayed Draw Term Loan, and a $450M revolving
AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity, Reduced Cost of Debt, and Enhanced Financial Flexibility
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth rallies after CEO buys $4.4M of shares
Shares of AdaptHealth (AHCO) are moving higher after the company’s CEO Richard Cashin last night disclosed the purchase of 447,827 shares between March 19 and March 20 at an average
AdaptHealth Transcript: Leerink Global Healthcare Conference 2026
Major operational streamlining and technology investments have driven record setup times and census growth across core segments. Exclusive capitated contracts with major payers like Kaiser and Humana are fueling expansion, while divestitures and M&A refine the portfolio. Regulatory changes and payer mix shifts continue to shape strategy.
AdaptHealth Transcript: J.P. Morgan 2026 Global Leveraged Finance Conference
The company is expanding its market share in sleep and respiratory care, leveraging technology and operational improvements to drive high adherence and patient satisfaction. Major contracts with Humana and Kaiser are fueling geographic growth, especially on the West Coast, while regulatory changes and industry consolidation present further opportunities.
HALPER SADEH LLC ENCOURAGES ADAPTHEALTH CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is invest...
AdaptHealth price target lowered to $9.50 from $10.50 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on AdaptHealth (AHCO) to $9.50 from $10.50 and keeps a Hold rating on the shares. Published first on TheFly – the ultimate source
AdaptHealth price target lowered to $14 from $15 at Canaccord
Canaccord lowered the firm’s price target on AdaptHealth (AHCO) to $14 from $15 and keeps a Buy rating on the shares. The firm said Adapt closed the year with much
AdaptHealth Earnings Call Transcript: Q4 2025
2025 saw record patient census, strong operational improvements, and the launch of the largest industry capitated contract, driving revenue and margin growth. Guidance for 2026 anticipates 6–8% revenue growth, margin expansion, and continued debt reduction, supported by technology and strategic acquisitions.
AdaptHealth reports Q4 EPS (76c), consensus 34c
Reports Q4 revenue $846.29M, consensus $831.6M. “2025 was a tremendous year of transition in which we made significant strides toward building a stronger operational and financial foundation,” said Su...
AdaptHealth sees FY26 revenue $3.44B-$3.51B, consensus $3.44B
Sees FY26 adjusted EBITDA $680M-$730M. Sees FY26 free cash flow $175M-$225M. The company said, “While fourth quarter 2025 Adjusted EBITDA was impacted by a legal settlement expense of $14.5 million
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2025 Results and Provides 2026 Financial Guidance
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Announces Upgraded Moody's Ratings
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...